Navigation Links
PRA International to Present Audioconference on Oncology Research - Nov. 8
Date:10/23/2007

PRA Oncology Expert to Speak

RESTON, Va., Oct. 23 /PRNewswire-FirstCall/ -- PRA International (Nasdaq: PRAI) today announced that Dr. Ute Berger, the company's senior director of therapeutic expertise and a specialist in oncology and hematology, will present a one-hour audioconference on conducting global clinical research in oncology on Thursday, Nov. 8, 2007 at 11:30 a.m. EST. In "Challenges in Conducting Global Oncology Trials," Dr. Berger will recommend ways to mitigate risk in terms of timelines and costs.

The audioconference will be of special interest to leaders in pharmaceutical and biotechnology research and development, clinical development, operations, clinical studies, outsourcing, procurement, and global data management. The registration fee is US$199 per phone line. For more information and to register, go to http://www.fxtrans.com/resources/ac/future/ac20071108.htm.

The speaker earned her medical degree from Germany's University of Heidelberg where she has served in senior positions on the Faculty of Clinical Medicine for nearly 20 years. Dr. Berger holds medical certifications in internal medicine, oncology and hematology, and is certified by the European Society of Medical Oncology. She has held numerous high-visibility positions, including as medical coordinator for the German CML Study Group, general manager of the German Competence Network "Acute and Chronic Leukemias" and scientific network manager of the "European LeukemiaNet."

Dr. Berger has established relationships with key opinion leaders in the hematology/oncology field around the world. Widely published, she is known for her expertise in clinical research and has significant experience overseeing, directing and implementing global oncology trials in a variety of indications.

The audioconference is presented in cooperation with ForeignExchange Translations, Inc., the leader in providing linguistic services to medical device, pharmaceutical and biotech companies.

About PRA International

PRA International is one of the world's leading global clinical development organizations, with over 2,700 employees working from offices in North America, Europe, Asia, South America, Africa and Australia. PRA is committed to delivering reliable service, program-level therapeutic expertise, easy, global access to knowledge and an involved senior management.

To learn more about PRA International, please visit http://www.prainternational.com or call our World Headquarters at +1 (703) 464-6300.


'/>"/>
SOURCE PRA International
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Olympics of biotechnology has international flavor
2. Traffic data firm navigates international business
3. Catalyst International profit exceeds expectations
4. Lack of broadband hamstrings international videoconferencing
5. 30 days to success: Three simple steps to create your own international startup
6. TEKLYNX International announces new RFID software
7. Ruling enforces international trademark electronic filing requirements
8. Eleftheriou to lead Catalyst International
9. Internet trademark war goes international
10. International eyes drawn to Madisons games research
11. Plexus and SRI International team up to offer medical product development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... ... March 23, 2017 , ... ... today announced the hire of Dr. Sigmund “Sig” Floyd as Vice President ? ... partnerships and joint development activities. , “Dr. Floyd’s career has spanned 30 years ...
(Date:3/22/2017)... Good Start Genetics, a leading family genomics ... million covered lives mark through its most recent payor ... . With newly signed contracts nationally and others ... payor acceptance based on the quality of its science, ... its industry-leading customer care and support and its published ...
(Date:3/22/2017)... 22, 2017 /PRNewswire/ - FACIT announced a seed ... "Propellon"), a start-up created by FACIT focused on ... investment, combined with non-dilutive capital, achieves a targeted ... funding enables Propellon to accelerate the nomination of ... financing and/or entering a strategic partnership for clinical ...
(Date:3/22/2017)... ... March 21, 2017 , ... Proper glycosylation is critical ... desired increase and/or decrease in antibody-dependent cellular cytotoxicity or complement-dependent cytotoxicity, there is ... antibodies. , To meet this demand, the team at SCIEX has developed ...
Breaking Biology Technology:
(Date:3/2/2017)... Summary This report provides all ... and its partnering interests and activities since 2010. ... The Partnering Deals and Alliance since 2010 report provides ... of the world,s leading life sciences companies. ... ensure inclusion of the most up to date deal ...
(Date:2/28/2017)... -- News solutions for biometrics, bag drop and New ... At ... 16 March, Materna will present its complete end-to-end passenger journey, ... a real benefit for passengers. To accelerate the whole passenger ... point solutions to take passengers through the complete integrated process ...
(Date:2/22/2017)... , Feb. 22, 2017 With ... 2021, ABI Research identifies four technologies that innovative ... to secure significant share in the changing competitive ... and passive authentication.   "Companies can ... comes to security," says Dimitrios Pavlakis , ...
Breaking Biology News(10 mins):